Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Epidermolysis Bullosa 101: Understanding the Framework
Description
Epidermolysis Bullosa (EB) is a group of blistering skin disorders caused by mutations in 16 identified genes, leading to varying degrees of skin fragility and blister formation upon minimal trauma. The four main types of EB are EB simplex, junctional EB, dystrophic EB, and Kindler syndrome, each differing by the severity and location of the genetic mutations in the epidermis or dermis. EB simplex usually causes superficial blisters that heal without scarring, while junctional EB and dystrophic EB can result in deeper, more severe blistering, scarring, and complications like oral and ocular issues, nail dystrophy, and systemic problems, including infections and malnutrition. Recently, two FDA-approved topical treatments have emerged for EB, applicable for patients aged six months and older. Managing EB requires a multidisciplinary approach, involving specialists such as dermatologists, nutritionists, dentists, and mental health professionals to support patients and their families comprehensively. Challenges faced by patients can include frequent infections, growth failure, and the psychological impact of living with the disease. Support groups and camps are also beneficial for patients, contributing positively to their community and well-being.
View moreConclusions
- Epidermolysis bullosa (EB) is a group of blistering disorders caused by mutations in over 16 genes, leading to varying degrees of skin fragility.
- The four major types of EB are EB simplex, junctional EB, dystrophic EB, and Kindler syndrome, each with distinct clinical presentations.
- EB simplex typically causes superficial blisters that heal without scarring, while junctional EB and dystrophic EB can cause more severe blistering and scarring.
- Kindler syndrome features a mixed phenotype, which includes blistering and severe photosensitivity.
- Recent FDA approvals have introduced topical treatments for EB, specifically targeting different types of the disorder.
- EB affects not only the skin but also internal organs, such as the oral and esophageal mucosa, and can lead to complicated systemic issues.
- The disease often causes significant psychosocial impacts, including effects on mental health and family dynamics.
- A comprehensive multidisciplinary approach involving various specialists is essential for effective management of patients with EB.
- Regular referrals to specialists in dermatology, gastroenterology, nutrition, dentistry, and psychology are crucial for holistic patient care.
- Modified from Bolognia
- From Hurwitz
- doi: 10.1542/neo.22-7-e438.